Written by: Illuminant Surgical
Illuminant’s team recently traveled to New York City to showcase its platform to top neurosurgeons at Mount Sinai, including Chairman Dr. Joshua Bederson and Vice-Chair Dr. J Mocco. The demonstration highlighted Illuminant’s ability to …
October 2, 2023
Illuminant Surgical’s clinical research team presented multiple projects at the Congress of Neurological Surgeons (CNS) 2023 Annual Meeting. In an oral presentation, the team presented its findings on 3D-navigated procedures vs 2D-fluoroscopy guided procedures. …
September 13, 2023
Illuminant’s clinical research team presented pioneering work at the American Society of Pain and Neuroscience (ASPN) 2023 Annual Conference in Miami Beach, FL. This first-of-its-kind review explores the adoption of emerging technologies—including extended reality, …
July 15, 2023
Illuminant Surgical was invited to present its groundbreaking navigation system at a Johnson & Johnson Medtech Innovation showcase, an event highlighting cutting-edge advancements in medical technology. The event provided an opportunity to demonstrate Illuminant’s …
June 7, 2023
Illuminant recently completed a preliminary cadaveric study at the Rhode Island Health Orthopedic Foundation, where neurosurgeons from Mount Sinai and Massachusetts General Hospital successfully placed thoracolumbar instrumentation using Illuminant’s platform. Postoperative scans confirmed high …
March 2, 2023
TechCrunch named Illuminant Surgical as one of its top picks from Y Combinator’s Summer 2022 Demo Day, distinguishing the company from hundreds of other startups in the competitive S22 batch. This recognition highlights Illuminant’s …
September 8, 2022